levodopa has been researched along with Polycystic Ovarian Syndrome in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lobo, RA; Shoupe, D | 1 |
| Faglia, G; Moriondo, P; Nissim, M; Travaglini, P | 1 |
| Acar, B; Kadanali, S | 1 |
| Huh, KB; Lee, BS; Lee, EJ; Lee, HC; Park, KH; Song, CH | 1 |
| Gu, Q; Su, Y; Wu, X | 1 |
| Erkkola, R; Pöllänen, P; Sallinen, K; Su, Y; Wu, X; Zhou, S | 1 |
| Goldfarb, AF | 1 |
| Perić, LA; Prelević, GM; Würzburger, MI | 1 |
| Artal, R; Barnes, RB; Lobo, RA | 1 |
| Barnes, RB; Lobo, RA | 1 |
1 trial(s) available for levodopa and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome.
Topics: Adult; Androgens; Androstenedione; Estradiol; Female; Follicle Stimulating Hormone; Human Growth Hormone; Humans; Infertility, Female; Insulin-Like Growth Factor I; Levodopa; Luteinizing Hormone; Obesity; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 2000 |
9 other study(ies) available for levodopa and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Evidence for altered catecholamine metabolism in polycystic ovary syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Carbidopa; Catecholamines; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Homovanillic Acid; Humans; Levodopa; Luteinizing Hormone; Methoxyhydroxyphenylglycol; Pituitary Hormone-Releasing Hormones; Polycystic Ovary Syndrome | 1984 |
Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
Topics: Adenoma; Adolescent; Adult; Carbidopa; Diagnosis, Differential; Female; Humans; Isoquinolines; Levodopa; Male; Middle Aged; Nomifensine; Pituitary Neoplasms; Polycystic Ovary Syndrome; Prolactin | 1980 |
Diminished growth hormone responses to L-dopa in polycystic ovarian disease.
Topics: Adolescent; Adult; Body Mass Index; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Kinetics; Levodopa; Luteinizing Hormone; Polycystic Ovary Syndrome; Prospective Studies | 1993 |
Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome.
Topics: Adolescent; Adult; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Levodopa; Polycystic Ovary Syndrome; Premedication; Pyridostigmine Bromide | 1993 |
[Responses of growth hormone and prolactin to L-Dopa in women with polycystic ovarian syndrome].
Topics: Adult; Female; Growth Hormone; Humans; Levodopa; Polycystic Ovary Syndrome; Prolactin | 1997 |
Polycystic ovarian disease: clinical considerations.
Topics: Androstenedione; Contraceptives, Oral; Estradiol; Estrone; Female; Gonadotropins; Humans; Levodopa; Luteinizing Hormone; Ovulation; Polycystic Ovary Syndrome; Testosterone; Vaginal Smears | 1977 |
Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
Topics: Adult; Bromocriptine; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Hyperprolactinemia; Levodopa; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin | 1987 |
Peripheral dopamine metabolism in polycystic ovary syndrome.
Topics: Adult; Carbidopa; Dopamine; Female; Homovanillic Acid; Humans; Levodopa; Methoxyhydroxyphenylglycol; Norepinephrine; Polycystic Ovary Syndrome | 1987 |
Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation.
Topics: Adult; Brain Chemistry; Carbidopa; Dopamine; Endorphins; Estrogens; Female; Follicle Stimulating Hormone; Humans; Levodopa; Luteinizing Hormone; Naloxone; Polycystic Ovary Syndrome; Prolactin | 1985 |